CDSCO
Uzbekistan Child Deaths From India-Made Cough Syrup: CDSCO Says Will Investigate the Allegation Against Noida-Based Manufacturing Firm
India-Made Cough Syrups Under CDSCO Probe After WHO Issues Alert Following Deaths of 66 Children in Gambia
Molnupiravir, COVID-19 Antiviral Drug, Launched in India at Rs 1,399 For Mild to Moderate Infection
Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO In Fight Against COVID-19
COVID-19 Vaccine Update: India's First mRNA Based COVID-19 Vaccine's Phase-I Clinical Trial Gets Nod
Indian Drug Regulator Approves Study on Mixing of COVID-19 Vaccines Covaxin, Covishield Doses
Monoclonal Antibodies Cocktail: Zydus Cadila, First India Company to Get Permission for Clinical Trials of Biological Therapy ZRC-3308 to Treat COVID-19, Says Sources
Google Trends